NUVL Research and Charts

NUVL - Nuvalent Inc Class A (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-05 (Delayed quote data 2025-09-12)

Last 80.47	Change ⇓ -1.75 (-2.13%)	Volume 405,266
	Open 81.99	High 82.40	Low 80.13

8EMA (Daily) 79.62	40EMA (Daily) 77.93	50EMA (Daily) 77.81	STO (Daily) 72.704	MACD Hist (Daily) 0.983
8EMA (Weekly) 78.530	40EMA (Weekly) 78.17	50EMA (Weekly) 77.89	STO (Weekly) 47.136	MACD Hist (Weekly) 0.670


Company Profile
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.